Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Xenon Pharmaceuticals Inc.”

102 pharma patents match "Xenon Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 102
Index total 30,257
Page 2 / 5

Quick answer

This filtered view shows 102 pharmaceutical patents matching "Xenon Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

102 results for “Xenon Pharmaceuticals Inc.” · 30,257 patents in full index Clear search

  1. US 10125098

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted
  2. US 10118932

    Solid state forms of spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted
  3. US 10071957

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  4. US 10005724

    Therapeutic compounds and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jun 26, 2018 · Expires Jun 21, 2038

    granted
  5. US 9771376

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  6. US 9695185

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted
  7. US 9694002

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jul 4, 2017 · Expires Jun 29, 2037

    granted
  8. US 9630929

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted
  9. US 9550775

    Substituted triazolopyridines and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted
  10. US 9546164

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 17, 2017 · Expires Jan 12, 2037

    granted
  11. US 9504671

    Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  12. US 9493429

    Substituted benzoxazoles and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted
  13. US 9487535

    Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  14. US 9481677

    Biaryl ether sulfonamides and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  15. US 9480677

    Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  16. US 9458178

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 4, 2016 · Expires Sep 29, 2036

    granted
  17. US 9278088

    Methods for identifying analgesic agents

    Xenon Pharmaceuticals Inc. · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted
  18. US 9260446

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  19. US 9187426

    Organic compounds

    Xenon Pharmaceuticals Inc. · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted
  20. US 9086420

    Methods for identifying analgesic agents

    Xenon Pharmaceuticals Inc. · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted
  21. US 8952169

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  22. US 8933236

    N-substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted
  23. US 8916580

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted
  24. US 8883840

    Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted